MedTrace Logo

PLH for Teens - Hybrid Delivery

NCT05071924 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1128

Last updated 2024-05-08

No results posted yet for this study

Summary

This study aims to examine the implementation and effectiveness of the original version of PLH Teens delivered in-person (PLH Teens-Original) and a hybrid in-person and remote delivery of the programme (PLH Teens-Hybrid) as part of the Mothers2Mothers' (M2M) Children and Adolescents are My Priority (CHAMP) project in Mpumalanga, South Africa. It will also examine differential effects between PLH Teens-Original and PLH Teens-Hybrid on reducing risks of violence against children using propensity score matching. Lastly, it will examine the implementation feasibility of PLH Teens-Hybrid in terms of implementation fidelity; recruitment, retention, and engagement of parents and adolescents; and the relevance, acceptability, and satisfaction of the programme.

Conditions

  • Child Maltreatment
  • Positive Parenting

Interventions

BEHAVIORAL

PLH Teens Original: In-person PLH programme for parents and teens by community-based workers

This in-person intervention is delivered over 14 sessions (10 joint parent and teen sessions and 4 separate parent and teen sessions).

BEHAVIORAL

PLH Teens Hybrid: Hybrid delivery for parents and teens by facilitators

The hybrid intervention delivered over 12 sessions (8 sessions delivered via WhatsApp groups to parents only and 4 sessions delivered in-person to parents and teens together).

Sponsors & Collaborators

  • Mothers2Mothers

    collaborator UNKNOWN

  • University of Cape Town

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Jamie M. Lachman, DPhil · University of Oxford

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-07-05
Primary Completion
2021-12-31
Completion
2022-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071924 on ClinicalTrials.gov